Archives

by in
Entry Author Date Location
Hungrier Investors, Loosened Regulations Could Spur More Local IPOs 04/16/13 Boulder/Denver
New World of Crowdfunding Waits as SEC Struggles to Complete its Job 04/09/13 Boulder/Denver
Enzon, under Pressure from Carl Icahn, Seeks Buyer 12/17/12 New York
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Celgene, Sanofi, Stryker Execs Charged With Insider Trading 11/19/12 New York
Silicon Valley Debates the Do’s and Don’ts of Equity Crowdfunding 09/26/12 San Francisco
CircleUp Brings Crowdfunding, Of a Sort, to Non-Tech Firms 07/02/12 San Francisco
JOBS Act: Important Benefits for Startups Not on the IPO On-Ramp 06/12/12 Boston
Calcbench Looks to Help Budget-Minded Analysts Crunch Financial Data 11/08/11 Boston
Venture Industry Calls for Rules Changes to Reopen IPO Market 10/20/11 National
Sequenom Inaugurates New Diagnostic Test for Down Syndrome 10/17/11 San Diego
Y Combinator’s Summer 2011 Demo Day: The Definitive Debrief, Part 1 08/24/11 San Francisco
SecondMarket Attempts to Sell Startups on the Value of Letting Employees Trade Their Stock 08/18/11 San Francisco
Metabolic Solutions Raises Another $6.8M 08/15/11 Detroit
Venture-Backed Buyouts at Record Volume as Increasing Pace of Exits Mark Possible Recovery 01/03/11 National
Filing: Webfilings Adds $5.1M 07/12/10 San Francisco
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News 06/03/10 San Diego
Startup Elcelyx Raises $1.2 Million 03/18/10 San Diego
Sequenom Down Syndrome Results “Deliberately Doctored,” Says Partner Xenomics 12/17/09 San Diego
UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News 10/29/09 San Diego
Optherion Sells $5M in Convertible Notes and Warrants 09/17/09 Boston
Of Phase Forward, MedVentive, and iMedX—Today’s New England Heath IT Deals Round-Up 07/15/09 Boston
Salient Surgical Cuts $86M IPO 08/27/08 Boston
Exact Sciences Puts Itself on the Block After Investor’s Prodding 03/18/08 Boston
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News 03/05/08 Boston
Verenium Files $150 Million Shelf Registration 11/15/07 Boston
Genzyme CEO Nets $9.3 Million From Options 10/31/07 Boston
Page 1 of 1